MarketCap
Facebook
X
TelegramQuarterly report 2023-Q3
added 11-08-2023
Invitae Corporation ROE Ratio 2011-2026 | NVTA
Annual ROE Ratio Invitae Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -98.02 | -6.89 | -30.47 | -63.74 | -79.93 | -101.3 | -101.19 | -64.88 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -6.89 | -101.3 | -68.3 |
Quarterly ROE Ratio Invitae Corporation
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 524.53 | 248.01 | -508.75 | -849.87 | -856.76 | -673.57 | -14.62 | -12.83 | -17.8 | -16.63 | -30.09 | -30.47 | -38.87 | -54.39 | -58.8 | -63.74 | -61.92 | -60.79 | -67.53 | -79.93 | -94.74 | -97.63 | -179.38 | -258.38 | -250.22 | -328.95 | -328.87 | -328.79 | -321.32 | -236.36 | -152.65 | -64.88 | -28.97 | 2.41 | 32.55 | 56.82 | 38.51 | 23.42 | 10.81 | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 524.53 | -856.76 | -134.14 |
ROE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-170.35 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
22.45 | $ 116.92 | 2.67 % | $ 35.5 B |  USA |
 |
Aspira Women's Health
AWH
|
184.36 | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
-362.16 | - | -13.05 % | $ 7.29 M | USA |
 |
BioNano Genomics
BNGO
|
-59.42 | $ 1.18 | 0.85 % | $ 6.43 M | USA |
 |
Chembio Diagnostics
CEMI
|
-130.86 | - | 0.22 % | $ 16.8 M | USA |
 |
Enzo Biochem
ENZ
|
-46.47 | - | -8.98 % | $ 14.8 K | USA |
 |
DermTech
DMTK
|
-176.45 | - | -11.32 % | $ 2.94 M | USA |
 |
CareDx, Inc
CDNA
|
-7.05 | $ 17.92 | 1.41 % | $ 955 M | USA |
 |
Exact Sciences Corporation
EXAS
|
-8.66 | - | - | $ 19.8 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.85 | - | - | $ 562 M |  Britain |
|
Akumin
AKU
|
325.23 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Burning Rock Biotech Limited
BNR
|
-43.17 | $ 16.24 | 0.93 % | $ 175 M |  China |
 |
Co-Diagnostics
CODX
|
-227.33 | $ 4.4 | 101.83 % | $ 5.85 M | USA |
 |
Heska Corporation
HSKA
|
-4.71 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-400.51 | - | -20.0 % | $ 1.06 M | USA |
 |
Interpace Biosciences
IDXG
|
109.89 | $ 1.98 | -0.63 % | $ 8.76 M | USA |
 |
Illumina
ILMN
|
-51.54 | $ 128.0 | 1.23 % | $ 20.4 B | USA |
 |
Accelerate Diagnostics
AXDX
|
65.62 | - | -61.36 % | $ 2.46 M | USA |
 |
Castle Biosciences
CSTL
|
4.0 | $ 25.19 | 1.45 % | $ 700 M | USA |
 |
Global Cord Blood Corporation
CO
|
10.27 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
-38.13 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-43.4 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-181.33 | - | 0.12 % | $ 80.1 M | China |
 |
Laboratory Corporation of America Holdings
LH
|
10.17 | $ 274.72 | 2.06 % | $ 22.9 B | USA |
 |
Charles River Laboratories International
CRL
|
-4.56 | $ 175.07 | 3.26 % | $ 8.68 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
13.32 | - | - | $ 10.7 B | USA |
 |
Medpace Holdings
MEDP
|
98.27 | $ 520.65 | 2.39 % | $ 15 B | USA |
 |
Danaher Corporation
DHR
|
6.88 | $ 196.19 | 2.71 % | $ 140 B | USA |
 |
Motus GI Holdings
MOTS
|
-478.86 | - | -34.28 % | $ 263 K |  Israel |
 |
Myriad Genetics
MYGN
|
-99.43 | $ 4.77 | 0.63 % | $ 442 M | USA |
 |
Neogen Corporation
NEOG
|
-52.72 | $ 10.34 | 3.61 % | $ 2.24 B | USA |
 |
National Research Corporation
NRC
|
82.92 | $ 17.26 | 1.29 % | $ 386 M | USA |
 |
Natera
NTRA
|
-77.62 | $ 210.83 | 0.75 % | $ 20.7 B | USA |
 |
Organovo Holdings
ONVO
|
-23.71 | - | -2.3 % | $ 19.4 M | USA |
 |
OpGen
OPGN
|
162.49 | - | -16.95 % | $ 1.54 M | USA |
 |
Fulgent Genetics
FLGT
|
-3.77 | $ 15.83 | -0.5 % | $ 479 M | USA |
 |
Pacific Biosciences of California
PACB
|
-10214.54 | $ 1.47 | 2.08 % | $ 441 M | USA |
 |
Guardant Health
GH
|
419.18 | $ 92.84 | -0.49 % | $ 11.6 B | USA |
 |
PerkinElmer
PKI
|
3.33 | - | -0.91 % | $ 14.7 B | USA |
 |
QIAGEN N.V.
QGEN
|
11.25 | - | - | $ 10.6 B |  Niderland |
 |
Psychemedics Corporation
PMD
|
-62.26 | - | -1.84 % | $ 15.3 M | USA |
 |
Personalis
PSNL
|
-40.05 | $ 6.33 | 2.59 % | $ 375 M | USA |
 |
Anixa Biosciences
ANIX
|
-72.07 | $ 2.73 | 1.49 % | $ 88.6 K | USA |
 |
Biomerica
BMRA
|
-121.14 | $ 2.15 | -0.46 % | $ 4.94 M | USA |
 |
Quotient Limited
QTNT
|
312.05 | - | -11.32 % | $ 1.1 M |  Schweiz |
 |
ICON Public Limited Company
ICLR
|
8.31 | $ 106.54 | -0.58 % | $ 8.79 B |  Irlanda |
 |
Check-Cap Ltd.
CHEK
|
1734.41 | - | - | $ 9.42 M | Israel |
 |
Celcuity
CELC
|
-176.06 | $ 116.94 | 1.19 % | $ 5.47 B | USA |